Acute lymphoblastic leukaemia: open trials in South Korea

17 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Asan Medical Center-Pediatrics - Pedicatric Oncology (Site 1973), Seoul · Seoul National University Hospital-Pediatrics (Site 1972), Seoul
Registry updated 2026-10-30
NCT07155226
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Trial Treatment · Phase 1/2 · AstraZeneca
Seoul
Registry updated 2026-10-23
NCT07109219
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1/2 · AstraZeneca
Seoul
Registry updated 2026-10-15
NCT07387926
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Seoul
Registry updated 2026-10-15
NCT06137118
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 1/2 · AstraZeneca
Seoul
Registry updated 2026-10-13
NCT06785818
Long-term Follow up Local Registry Study of Kymriah in South Korea
Research · Novartis Pharmaceuticals
Bundang Gu · Busan · Gyeonggi-do · Incheon · Jeollanam · Seongnam-si · Seoul · Ulsan
Registry updated 2026-07-30
NCT05827549
Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia
Trial Treatment · Phase 2 · Ho Joon Im
Kyungpook National University Chilgok Hospital, Daegu · Chungnam National University Hospital, Daejeon · Chonnam National University Hwasun Hospital, Hwasun · Jeju National University Hospital, Jeju City · Asan Medical Center, Seoul · Severance hospital, Seoul · Seoul National University Hospital, Seoul · Seoul saint Mary's Hospital, Seoul · Samsung Medical Center, Seoul · Pusan National University Yangsan Hospital, Yangsan
Registry updated 2026-07-29
NCT06099366
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
Trial Treatment · Phase 2 · Hee Young Ju
Kyungpook National University Chilgok Hospital, Daegu · Chungnam National University Hospital, Daejeon · Chonnam National University Hwasun Hospital, Hwasun · Jeju National University Hospital, Jeju City · Seoul National University Bundang Hospital, Seongnam · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul · Severance hospital, Seoul · Seoul saint Mary's Hospital, Seoul · Korea University Anam Hospital, Seoul · Samsung Medical Center, Seoul · Ajou University Medical Center, Suwon · Pusan National University Yangsan Hospital, Yangsan
Registry updated 2026-07-29
NCT06184009
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia
Trial Treatment · Phase 2 · Jae Wook Lee
Inha University Hospital, Incheon · Samsung Medical Center, Seoul · Severance hospital, Seoul · Asan Medical Center, Seoul · Korea University Anam Hospital, Seoul · Seoul saint Mary's Hospital, Seoul · Seoul National University Hospital, Seoul · Ajou University Hospital, Suwon · Pusan National University Yangsan Hospital, Yangsan
Registry updated 2026-07-29
NCT06257394
Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
Trial Treatment · Phase 2 · Hyoung Jin Kang
Kyungpook National University Chilgok Hospital, Daegu · Chungnam National University Hospital, Daejeon · Chonnam National University Hwasun Hospital, Hwasun · Jeju National University Hospital, Jeju City · Seoul saint Mary's Hospital, Seoul · Severance hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · Pusan National University Yangsan Hospital, Yangsan
Registry updated 2026-07-29
NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Busan · Jeollanam · Seoul · Uijeongbu-si
Registry updated 2026-07-06
NCT04836507
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients
Trial Treatment · Phase 1/2 · Curocell Inc.
The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Samsung Medical Center, Seoul
Registry updated 2026-07-01
NCT06051409
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.
Busan · Busan · Seoul · Seoul · Seoul · Uijeongbu-si
Registry updated 2026-04-30
NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
Chonnam National University Hwasun Hospital, Hwasun · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul · The Catholic University of Korea, Seoul
Registry updated 2026-03-24
NCT06712121
Venetoclax and Decitabine in R/R T-ALL
Trial Treatment · Phase 2 · Seoul National University Hospital
Seoul National University Bundang Hospital, Seongnam-si · Seoul National University Hospital, Seoul
Registry updated 2026-02-02
NCT06367920
Multicenter Study on Rehabilitation Medical Data for Pediatric Big Brain Development
Research · Bundang CHA Hospital
CHA Bundang Medical Center, CHA University, Seongnam-si
Registry updated 2025-09-17
NCT06247501
Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation
Trial Treatment · Phase 2 · Seoul National University Hospital
Seoul National University Children's Hospital, Seoul
Registry updated 2024-02-08

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error